Marc Duey
Known title: DirectorCIK: 0001925150
Marc Duey's purchase track record
Marc Duey has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 12/10/2025 | APRE | $25K | -13.7% | -17.2% | +5.5% |
| 10/14/2024 | APRE | $132K | +33.6% | -38.3% | -7.8% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| APRE | ▲ Buy | Grant | 3,135 | $0 | 6/16/2026 | View on chart |
| APRE | ▲ Buy | Open Market | 21,459 | $25K | 12/10/2025 | View on chart |
| APRE | ▲ Buy | Grant | 1,045 | $0 | 6/5/2025 | View on chart |
| APRE | ▼ Sell | Open Market | 6,462 | $30K | 10/18/2024 | View on chart |
| APRE | ▲ Buy | Open Market | 30,000 | $132K | 10/16/2024 | View on chart |
| APRE | ▲ Buy | Open Market | 190 | $490 | 10/14/2024 | View on chart |
| APRE | ▲ Buy | Grant | 1,045 | $0 | 6/20/2024 | View on chart |
| APRE | ▲ Buy | Grant | 500 | $0 | 8/23/2023 | View on chart |
| APRE | ▼ Sell | Other | 11,610 | $0 | 8/23/2022 | View on chart |
| APRE | ▼ Sell | Other | 4,009,690 | $0 | 8/23/2022 | View on chart |
| APRE | ▲ Buy | Grant | 5,995 | $0 | 7/28/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 6, 2026
Aprea Therapeutics Announces October Conference Presentations
Aprea Therapeutics will present at several conferences in October. The company’s appearance is intended to share progress on its research and development efforts. The presentation may offer new information to investors and analysts about the company’s pipeline and strategy. The event is a routine update for the company’s stakeholders.
Aprea Therapeutics Announces October Conference Presentations. Aprea Therapeutics will present at several conferences in October. The company’s appearance is intended to share progress on its research and development efforts. The presentation may offer new information to investors and analysts about the company’s pipeline and strategy. The event is a routine update for the company’s stakeholders.